AQR Capital Management
DNA icon

AQR Capital Management’s Ginkgo Bioworks DNA Stock Holding History

AQR Capital Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
294,788
+124,233
+73% +$1.03M ﹤0.01% 2421
2025
Q4 		$1.42M Buy
170,555
+19,860
+13% +$214K ﹤0.01% 2350
2025
Q3 		$2.2M Sell
150,695
-13,095
-8% -$157K ﹤0.01% 1923
2025
Q2 		$1.84M Buy
163,790
+4,851
+3% +$37.6K ﹤0.01% 1825
2025
Q1 		$906K Buy
158,939
+121,326
+323% +$1.24M ﹤0.01% 2088
2024
Q4 		$369K Sell
37,613
-2,818
-7% -$24.2K ﹤0.01% 2400
2024
Q3 		$330K Sell
40,431
-218,647
-84% -$2.19M ﹤0.01% 2357
2024
Q2 		$3.39M Buy
+259,078
New +$7.73M 0.01% 1212
2024
Q1 		– Sell
-980
Closed -$66.3K – 2436
2023
Q4 		$66.3K Buy
980
+393
+67% +$24.1K ﹤0.01% 2296
2023
Q3 		$42.4K Buy
+587
New +$46.9K ﹤0.01% 2291
2022
Q4 		– Sell
-15,310
Closed -$1.91M – 2216
2022
Q3 		$1.91M Buy
+15,310
New +$1.82M ﹤0.01% 1222

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return